Wendy future of retail top

Camber launches generic Valcyte

Camber unveils generic Valcyte

Camber unveils generic Valcyte

PISCATAWAY, N.J. –  Camber Pharmaceuticals announced the addition of valganciclovir for oral solution to its current portfolio. Valganciclovir for oral solution is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for: Adult Patients: •  Treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). •  Prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients

PP_1170x120_10-25-21